Discovery of novel candidate urinary protein biomarkers for prostate cancer in a multiethnic cohort of South African patients via label-free mass spectrometry.


PURPOSE Improvement in diagnostic accuracy of prostate cancer (PCa) progression using MS-based methods to analyze biomarkers in our African, Caucasian, and Mixed Ancestry patients can advance early detection and treatment monitoring. EXPERIMENTAL DESIGN MS-based proteomic analysis of pooled (N = 36) and individual samples (N = 45) of PCa, benign prostatic… (More)
DOI: 10.1002/prca.201400197


  • Presentations referencing similar topics